Tepha Revenue and Competitors
Estimated Revenue & Valuation
- Tepha's estimated annual revenue is currently $3.4M per year.
- Tepha's estimated revenue per employee is $125,500
- Tepha's total funding is $60.2M.
Employee Data
- Tepha has 27 Employees.
- Tepha grew their employee count by -4% last year.
Tepha's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director | Reveal Email/Phone |
Tepha Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11M | 44 | 13% | N/A | N/A |
#2 | $11M | 44 | 29% | N/A | N/A |
#3 | $4.3M | 17 | 0% | N/A | N/A |
#4 | $3.8M | 15 | -29% | N/A | N/A |
#5 | $5630M | 9122 | -11% | $450M | N/A |
#6 | $4.3M | 17 | 0% | N/A | N/A |
#7 | $4M | 16 | -72% | $23.5M | N/A |
#8 | $44.4M | 177 | 9% | N/A | N/A |
#9 | $45.7M | 182 | 0% | N/A | N/A |
#10 | $15M | 79 | 8% | $105.2M | N/A |
What Is Tepha?
Tepha was incorporated in 1998 following a successful collaboration between our sister company, Metabolix, Inc. (Cambridge, MA) & Children’s Hospital, Boston in project involving cardiovascular tissue engineering. Surgeons at Children’s Hospital had been attempting to develop a tissue engineered heart valve that could grow with the patient. Such a product would represent a quantum leap in heart valve surgery for the pediatric population, eliminating the need to replace the valve after a few yrs. Using the Company’s proprietary technology, Tepha was able to successfully produce a biomaterial scaffold suitable for tissue engineered valves. The results of subsequent experiments were astounding. It was found that newly implanted valves grew with their recipients, & its scaffolds completely remodeled into new heart valve tissue that resembled the native tissues within 6 to 8 weeks.
keywords:Healthcare
$60.2M
Total Funding
27
Number of Employees
$3.4M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Tepha News
... Mesh Market Size, Outlook And Forecast | Ethicon, ALTAYLAR MEDICAL, Bio-Rad, Molnlycke Healthcare, C.R. Bard, Tepha, Atrium, Medtronic.
Most recently, Ian was Vice President and Chief Financial Officer of Tepha, Inc. (acquired by Becton, Dickson and Company), a proprietary...
Tepha, Inc., a Lexington, MA-based developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology, has received a $3.2m credit facility from GE Capital, Healthcare Financial Services. The financing provides the company ...
Tepha Inc. stitched up nearly $3 million in new funding from a group of un-named investors, according to a filing with the federal Securities and Exchange Commission. The Lexington, Mass.-based company, a 1998 spinout from Cambridge, Mass.-based Metabolix (NSDQ:MBLX), is developing absorbable p ...
Other Companies in Lexington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.2M | 27 | 0% | N/A |
#2 | $3.1M | 27 | 13% | N/A |
#3 | $4.2M | 27 | 0% | $64M |
#4 | $5.1M | 27 | 13% | N/A |
#5 | $5.1M | 27 | 17% | N/A |